


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
+0.21%
+4.73%
-1.57%
+5.80%
-6.45%
NUTX
Nutex Health
$162.50
Strengths

Earnings are forecast to grow
NUTX Price Performance
$114.65 (+41.74%)
$92 (+76.63%)
$104.08 (+56.13%)
$29.4 (+452.72%)
NUTX has Fair risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

Low volume

High volatilty

NUTX overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Revenue increase YoY

Above analyst estimates
Rating
Rating
Momentum
Momentum

Has been gaining momentum
Activity
Activity
Future
Future

Earnings are forecast to grow
![]()
NUTX Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential
NUTX Street Sentiment is extremely bullish and have positive views on the near-term outlook
Average key support and resistance price levels
Login to displayWhat is NUTX current stock price?
What are NUTX stock strengths?
What is NUTX Risk Level?
What is NUTX market cap and volume?
What is NUTX current Stock IQ?
Should I buy NUTX stock right now?
Is NUTX a Strong Buy right now?
What does a 'Strong Buy' rating mean for NUTX?
What does a 'Strong Sell' rating mean for NUTX?
What factors influence NUTX's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+0.21%
+4.73%
-1.57%
+5.80%
-6.45%
NUTX
Nutex Health
Current Price
$162.50
Stock Insights
Strengths

Earnings are forecast to grow

NUTX Price Performance
$114.65 (+41.74%)
$92 (+76.63%)
$104.08 (+56.13%)
$29.4 (+452.72%)
NUTX Analysts Opinion
NUTX Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Revenue increase YoY

Above analyst estimates
Rating
Rating
Momentum
Momentum

Has been gaining momentum
Activity
Activity
Future
Future

Earnings are forecast to grow
![]()
NUTX Analysts opinion is negative and it remained unchanged from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential
NUTX Street Sentiment is extremely bullish and have positive views on the near-term outlook
NUTX has Fair risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

Low volume

High volatilty

Average key support and resistance price levels
NUTX Stock IQ
NUTX Latest Analysis
Nutex Health extends share repurchase plan.
Thu Dec 4, 2025
Nutex Health Extends $25 Mln Share Buyback Program Through March 2026 . (RTTNews) - Nutex Health Inc. (NUTX) on Thursday announced its Board has extended the companys previously authorized $25 million share repurchase program through March 31 2026.
Thu Dec 4, 2025
NUTEX HEALTH EXTENDS SHARE REPURCHASE PLAN. HOUSTON Dec. 4 2025 /PRNewswire/ -- Nutex Health Inc. (Nutex Health or the Company) (NASDAQ: NUTX) a physician-led integrated healthcare delivery system comprised of 25 state-of-the-art micro hospitals and hospital outpatient departments in 11 states and primary care-centric...
Thu Dec 4, 2025
Nutex Health extends share repurchase program through March 2026.
Thu Dec 4, 2025
Nutex Health extends share buyback program through March 2026.
Thu Dec 4, 2025
NUTEX HEALTH RESPONDS TO SHORT SELLER REPORT. HOUSTON Nov. 26 2025 /PRNewswire/ -- Nutex Health Inc. (Nutex Health or the Company) (NASDAQ: NUTX) is aware of a short seller report issued on November 25 2025 by Capybara Research. Based on publicly available information Capybara Research as an entity seems not to exist. In the...
Wed Nov 26, 2025
Nutex Health responds to short seller report questions source credibility.
Wed Nov 26, 2025
Nutex Health Posts Strong Q3 Results Joins PACS Group Walmart Cerence And Other Big Stocks Moving Higher On Thursday. United States stocks were higher with the Dow Jones gaining more than 250 points on Thursday.Shares of ) rose sharply during Thursday'.s session after the company reported better-than-expected third-quarter financial results.Nutex Health posted quarterly sales of $267.804 million beating market estimates of $213.812 million.Nutex Health shares jumped 37.3% to $154.14 on Thurs
Thu Nov 20, 2025
Nutex Healths Q3 Revenue Jumps More Than Threefold . (RTTNews) - Nutex Health Inc. (NUTX) reported robust earnings and revenue growth for the third quarter and nine months ended September 30 2025 sharply outpacing its 2024 performance.
Thu Nov 20, 2025
Nutex Health Delivers Explosive Growth But Faces A Critical Prove It Moment.
Wed Nov 19, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
NUTX Stock trends
NUTX Stock performance
NUTX Stock analysis
NUTX investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.